Log in to save to my catalogue

Argininemia: Pathophysiology and Novel Methods for Evaluation of the Disease

Argininemia: Pathophysiology and Novel Methods for Evaluation of the Disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b342251f31dc45e8b9c7cfa641bb13cd

Argininemia: Pathophysiology and Novel Methods for Evaluation of the Disease

About this item

Full title

Argininemia: Pathophysiology and Novel Methods for Evaluation of the Disease

Publisher

Basel: MDPI AG

Journal title

Applied sciences, 2024-02, Vol.14 (4), p.1647

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

Argininemia or arginase-1 deficiency constitutes a rare, genetic, metabolic disorder caused by mutations in arginase 1—the last enzyme of the urea cycle—that hydrolyses L-arginine to ornithine and urea. The disease is associated with progressive development of spasticity and other symptoms, including seizures, developmental delay, cognitive impairm...

Alternative Titles

Full title

Argininemia: Pathophysiology and Novel Methods for Evaluation of the Disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_b342251f31dc45e8b9c7cfa641bb13cd

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b342251f31dc45e8b9c7cfa641bb13cd

Other Identifiers

ISSN

2076-3417

E-ISSN

2076-3417

DOI

10.3390/app14041647

How to access this item